Outlook Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $50k | 126k | 0.39 |
| 2023-06-30 | $8.8k | 5.0k | 1.74 |
| 2023-03-31 | $9.9k | 9.1k | 1.09 |
| 2022-12-31 | $20k | 18k | 1.08 |
| 2022-06-30 | $999 | 1.4k | 0.70 |
| 2022-03-31 | $5.0k | 2.7k | 1.82 |
| 2021-12-31 | $44k | 32k | 1.36 |
| 2021-06-30 | $13k | 5.1k | 2.56 |
| 2021-03-31 | $15k | 6.9k | 2.19 |
| 2020-12-31 | $12k | 9.0k | 1.33 |
| 2020-09-30 | $5.0k | 7.5k | 0.67 |
| 2020-06-30 | $12k | 9.0k | 1.33 |
| 2020-03-31 | $0 | 187 | 0.00 |
| 2019-12-31 | $0 | 187 | 0.00 |
| 2019-09-30 | $0 | 3.7k | 0.00 |
| 2019-06-30 | $0 | 5.7k | 0.00 |
| 2019-03-31 | $1.0k | 187 | 5.35 |